upcoming events
Event Information:
-
Sat23May2020Tue26May2020Paris Expo Porte de Versailles, Paris, France
the 6th Congress of the European Academy of Neurology
EAN
The sessions will focus on showing the novel therapeutic interventions, designed to predict, protect and repair neurodegenerative diseases.
https://ipp-ean20.netkey.at/
Latest news
Orchard Therapeutics Receives EC Approval for Libmeldy™ for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD)
Press Release: Orchard Therapeutics BOSTON/LONDON/MILAN, December 21, 2020 – Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, and its research alliance partners Fondazione Telethon…
Newborn Screening Saves Lives Reauthorization
Thank you ALL for supporting last year’s sign on letter to add language to Newborn Screening Saves Lives Reauthorization which would fund states in order…
Research Study: Impact of COVID-19 on People Living with Rare Diseases and Their Families
The novel coronavirus pandemic can have a serious impact on people with rare diseases and their families. Yet, not much is known about it. We…
Patient Focused Drug Development Meeting on Krabbe Disease
NORD invites you to register for an externally-led Patient-Focused Drug Development (EL- PFDD) virtual meeting on Krabbe disease, taking place Thursday, October 29, 12:30 – 4:30 pm…
Taking Care of Yourself When Taking Care of Others
from BlueCross BlueShield of Illinois Look around and you’ll see caregivers. In the U.S., 1 in 3 adults give care to others. Caregivers may be…
Minoryx Nexus Clinical Study for cALD
Minoryx Therapeutics is recruiting for a clinical trial focusing on cALD in Europe. The NEXUS clinical trial is a phase 2, open-label clinical study designed…
Share your story
Dylan Joseph Changle, Krabbe Disease
Dylan was born on April 15, 2009, Daddy’s Little tax Deduction! For the first 5 months he progressed like a normal child, until one day,…
Kristie DeMarco, Refsum Disease
From PatientWorthy.com After coming back from the Global Genes conference, Kristie was convinced that establishing a foundation was the right next step to advocate for…
Sam Buck, VWM
“Until February 2013, our 2-year-old son Sam was completely normal child, no problems with his pregnancy or birth, he met every milestone, and overall was…